Genome Therapeutics, Genesoft Move Forward with Merger Plans | GenomeWeb

NEW YORK, Dec. 30 (GenomeWeb News) - Genome Therapeutics and Genesoft Pharmaceuticals today announced that the US Securities and Exchange Commission has approved a registration statement related to their proposed merger that includes a proxy statement that will be mailed to shareholders of both companies.

In addition, the companies said they will each hold a special meeting of their stockholders to vote on the proposed merger and other related matters on Feb. 2, 2004.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.